CEACAM Antibody Blocking peptide

Product Specifications

Product Name Alternative

Carcinoembryonic antigen-related cell adhesion molecule 1, Biliary glycoprotein 1, BGP-1, CD66a, CEACAM1, BGP, BGP1

UniProt

P13688

Field of Research

Epigenetics

Form

Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Notes

For research use only.

Applications Notes

Synthetic peptide

AA Sequence

The synthetic peptide sequence used to generate the antibody orb1929326 was selected from the N-term region of human CEACAM. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

More Discoveries

Explore Other Products

Browse additional items from our catalog

ARP66295_P050-HRP 100 µL

TAS2R16 Antibody - C-terminal region : HRP (ARP66295_P050-HRP)

View Details

040564-ML550 100 µL

PSMD14, CT (PSMD14, POH1, 26S proteasome non-ATPase regulatory subunit 14, 26S proteasome regulatory subunit RPN11, 26S proteasome-associated PAD1 homolog 1) (MaxLight 550) discontinued

View Details

MBS1021925-01 0.02 mg (E-Coli)

Recombinant Yersinia pseudotuberculosis serotype O:3 Quinolinate synthase A (nadA)

View Details

MBS1021925-02 0.02 mg (Yeast)

Recombinant Yersinia pseudotuberculosis serotype O:3 Quinolinate synthase A (nadA)

View Details

MBS1021925-03 0.1 mg (E-Coli)

Recombinant Yersinia pseudotuberculosis serotype O:3 Quinolinate synthase A (nadA)

View Details

MBS1021925-04 0.1 mg (Yeast)

Recombinant Yersinia pseudotuberculosis serotype O:3 Quinolinate synthase A (nadA)

View Details